OSUR ORASURE TECHNOLOGIES INC

8-K Current Report

Filed: February 25, 2026

Health Care

Surgical & Medical Instruments & Apparatus

ORASURE TECHNOLOGIES INC (OSUR) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 earnings released Feb 25, 2026 — full results in Exhibit 99.1
• Period covered: fiscal year and quarter ended December 31, 2025

+1 more insights

Item 7.01 · Regulation FD Disclosure

• OSUR management hosted analyst/investor webcast Feb 25, 2026 covering full-year and Q4 2025 financial results
• CEO Carrie Eglinton Manner and CFO Kenneth McGrath led call — key executives to monitor for forward guidance signals

+1 more insights

Other ORASURE TECHNOLOGIES INC 8-K Filings

8-K Mar 5, 2026

Get deeper insights on ORASURE TECHNOLOGIES INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.